Series B · Biotech
Osanni Bio: Series B
Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model
Funding history
Series B · This round$190M
Loading rounds…
Platform that discovers and de-risks novel drug programs in ophthalmology and cardiology via affiliate company model